Financial results - RAICU VIVAMED SRL

Financial Summary - Raicu Vivamed Srl
Unique identification code: 32916988
Registration number: J07/85/2014
Nace: 8621
Sales - Ron
71.063
Net Profit - Ron
46.014
Employee
1
The most important financial indicators for the company Raicu Vivamed Srl - Unique Identification Number 32916988: sales in 2023 was 71.063 euro, registering a net profit of 46.014 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Raicu Vivamed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 21.422 32.791 33.483 35.458 40.687 50.407 55.267 55.659 62.450 71.063
Total Income - EUR 21.422 32.791 33.483 35.458 40.687 50.407 55.267 55.660 62.451 71.064
Total Expenses - EUR 7.602 10.324 14.520 14.692 10.911 12.353 19.414 16.439 25.023 24.339
Gross Profit/Loss - EUR 13.821 22.467 18.963 20.767 29.776 38.054 35.854 39.221 37.428 46.724
Net Profit/Loss - EUR 13.178 21.485 18.628 20.501 29.370 37.550 35.301 38.664 36.803 46.014
Employees 2 2 2 1 1 1 3 2 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 14.1%, from 62.450 euro in the year 2022, to 71.063 euro in 2023. The Net Profit increased by 9.322 euro, from 36.803 euro in 2022, to 46.014 in the last year.

Check the financial reports for the company - Raicu Vivamed Srl

Rating financiar

Financial Rating -
Raicu Vivamed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Raicu Vivamed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Raicu Vivamed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Raicu Vivamed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Raicu Vivamed Srl - CUI 32916988

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 0 0 0 0 0 0
Current Assets 14.523 36.184 56.829 121.629 142.203 176.018 173.150 67.133 72.130 97.457
Inventories 0 27 67 0 0 0 0 0 0 0
Receivables 781 3.924 3.986 20.497 23.504 22.652 18.447 26.331 69.021 83.004
Cash 13.742 32.234 52.776 101.132 118.699 153.367 154.703 40.802 3.109 14.454
Shareholders Funds 13.233 34.828 53.101 72.704 100.739 136.338 169.054 58.414 40.648 72.477
Social Capital 56 56 56 55 54 53 52 51 51 51
Debts 1.290 1.356 3.729 48.926 41.464 39.680 4.095 8.719 31.483 24.980
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 97.457 euro in 2023 which includes Inventories of 0 euro, Receivables of 83.004 euro and cash availability of 14.454 euro.
The company's Equity was valued at 72.477 euro, while total Liabilities amounted to 24.980 euro. Equity increased by 31.953 euro, from 40.648 euro in 2022, to 72.477 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Raicu Vivamed Srl

Comments - Raicu Vivamed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.